288 related articles for article (PubMed ID: 31217420)
1. SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.
Mitrofanova A; Mallela SK; Ducasa GM; Yoo TH; Rosenfeld-Gur E; Zelnik ID; Molina J; Varona Santos J; Ge M; Sloan A; Kim JJ; Pedigo C; Bryn J; Volosenco I; Faul C; Zeidan YH; Garcia Hernandez C; Mendez AJ; Leibiger I; Burke GW; Futerman AH; Barisoni L; Ishimoto Y; Inagi R; Merscher S; Fornoni A
Nat Commun; 2019 Jun; 10(1):2692. PubMed ID: 31217420
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.
Ahmad A; Mitrofanova A; Bielawski J; Yang Y; Marples B; Fornoni A; Zeidan YH
FASEB J; 2017 Feb; 31(2):771-780. PubMed ID: 27836988
[TBL] [Abstract][Full Text] [Related]
3. SMPDL3b modulates radiation-induced DNA damage response in renal podocytes.
Francis M; Ahmad A; Bodgi L; Azzam P; Youssef T; Abou Daher A; Eid AA; Fornoni A; Pollack A; Marples B; Zeidan YH
FASEB J; 2022 Oct; 36(10):e22545. PubMed ID: 36094323
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes.
Mallela SK; Mitrofanova A; Merscher S; Fornoni A
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158517. PubMed ID: 31487557
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes.
Watanabe S; Hidenori U; Hashimoto S; Riko S; Aizawa T; Tsugawa K; Imaizumi T; Tanaka H
J Membr Biol; 2022 Feb; 255(1):117-122. PubMed ID: 34739556
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B.
Fan W; Tang S; Fan X; Fang Y; Xu X; Li L; Xu J; Li JL; Wang Z; Li X
Elife; 2021 May; 10():. PubMed ID: 34042046
[TBL] [Abstract][Full Text] [Related]
8. Modulation of radiation-induced damage of human glomerular endothelial cells by SMPDL3B.
Abou Daher A; Francis M; Azzam P; Ahmad A; Eid AA; Fornoni A; Marples B; Zeidan YH
FASEB J; 2020 Jun; 34(6):7915-7926. PubMed ID: 32293077
[TBL] [Abstract][Full Text] [Related]
9. SMPDL3B is palmitoylated and stabilized by ZDHHC5, and its silencing aggravates diabetic retinopathy of db/db mice: Activation of NLRP3/NF-κB pathway.
Zhou Y; Yue S; Li L; Zhang J; Chen L; Chen J
Cell Signal; 2024 Apr; 116():111064. PubMed ID: 38266744
[TBL] [Abstract][Full Text] [Related]
10. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B.
Liu B; Xiao J; Dong M; Qiu Z; Jin J
Cancer Sci; 2020 Jul; 111(7):2259-2274. PubMed ID: 32391585
[TBL] [Abstract][Full Text] [Related]
11. The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity.
Heinz LX; Baumann CL; Köberlin MS; Snijder B; Gawish R; Shui G; Sharif O; Aspalter IM; Müller AC; Kandasamy RK; Breitwieser FP; Pichlmair A; Bruckner M; Rebsamen M; Blüml S; Karonitsch T; Fauster A; Colinge J; Bennett KL; Knapp S; Wenk MR; Superti-Furga G
Cell Rep; 2015 Jun; 11(12):1919-28. PubMed ID: 26095358
[TBL] [Abstract][Full Text] [Related]
12. Lipid biology of the podocyte--new perspectives offer new opportunities.
Fornoni A; Merscher S; Kopp JB
Nat Rev Nephrol; 2014 Jul; 10(7):379-88. PubMed ID: 24861084
[TBL] [Abstract][Full Text] [Related]
13. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
14. Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.
Merscher S; Fornoni A
Front Endocrinol (Lausanne); 2014; 5():127. PubMed ID: 25126087
[TBL] [Abstract][Full Text] [Related]
15. Lipid mediators of insulin signaling in diabetic kidney disease.
Mitrofanova A; Sosa MA; Fornoni A
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1241-F1252. PubMed ID: 31545927
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
[TBL] [Abstract][Full Text] [Related]
17. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase.
Peraldi P; Hotamisligil GS; Buurman WA; White MF; Spiegelman BM
J Biol Chem; 1996 May; 271(22):13018-22. PubMed ID: 8662983
[TBL] [Abstract][Full Text] [Related]
19. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
[TBL] [Abstract][Full Text] [Related]
20. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
